AquAdvantage Salmon
The FDA approved a new animal drug application in November 2015, concerning AquAdvantage Salmon, a genetically engineered Atlantic salmon. Documents related to this approval are available below. News FDA Releases Draft Amended Environmental Assessment for AquAdvantage Salmon and Announces Virtual Public Meeting Statement from FDA Commissioner Scott Gottlieb, M.D., on continued efforts to advance s
リリース、障害情報などのサービスのお知らせ
最新の人気エントリーの配信
j次のブックマーク
k前のブックマーク
lあとで読む
eコメント一覧を開く
oページを開く
CFSAN Adverse Event Reporting System (CAERS)
Label Claims
Recalls, Market Withdrawals, & Safety Alerts
Food Defense Guidance Documents & Regulatory Information
FDA Answers Your Questions about Fish Drugs
GRAS Notice Inventory
FDA releases new tool to help prevent intentional food contamination
Food Science & Research
Nutrition Facts Label: 20 and Evolving
Guidance for Industry: Food Producers, Processors, and Transporters: Food Security Preventive Measures Guidance
http://www.fda.gov/downloads/Food/GuidanceComplianceRegulatoryInformation/GuidanceDocuments/FoodLabelingNutrition/FoodLabelingGuide/UCM254435.pdf
Drug Residues
Investigation of Multistate Outbreak of Human Infections Linked to Dry Pet Food
Industry Reminder: Labeling of Ethoxyquin in Animal Feed
Food Contaminants & Adulteration
http://www.fda.gov/Food/ResourcesForYou/Consumers/NFLPM/ucm274590.htm
Conditional Approval of Potassium Bromide for Dogs
FDA takes steps to protect public health
CVM Reports on Antimicrobials Sold or Distributed for Food-Producing Animals for 2010